Related Experiment Videos
Rheumatoid arthritis associated with hyperviscosity syndrome and intermediate complex formation
Archives of Internal Medicine
|February 1, 1975
Summary
Patients with rheumatoid arthritis can develop hyperviscosity syndrome due to intermediate complexes. These complexes are primarily composed of immunoglobulin G (IgG) and rheumatoid factor.
Area of Science:
- Rheumatology
- Immunology
- Hematology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
- Hyperviscosity syndrome (HVS) is a rare complication associated with certain hematological and autoimmune disorders.
- Abnormal protein complexes in plasma can lead to increased blood viscosity.
Purpose of the Study:
- To investigate the cause of hyperviscosity syndrome in a patient with long-standing rheumatoid arthritis.
- To identify the composition of intermediate plasma complexes associated with the syndrome.
Main Methods:
- Isolation and characterization of intermediate plasma complexes from the patient.
- Immunochemical analysis to determine the protein components of the isolated complexes.
Main Results:
- The patient presented with hyperviscosity syndrome.
- Abundant intermediate complexes were detected in the patient's plasma.
- These complexes were predominantly composed of immunoglobulin G (IgG) and rheumatoid factor (RF).
Conclusions:
- Hyperviscosity syndrome in this RA patient was linked to the presence of IgG-RF intermediate complexes.
- This finding highlights a potential mechanism for HVS in specific autoimmune conditions.
- Further research may elucidate the role of such complexes in RA pathogenesis and complications.